Please login to the form below

Not currently logged in

BMS' PD-1 blocker Opdivo aces lung cancer trial

Bristol Myers Squibb logo

41% of treated patients alive after 12 months

Novo Nordisk profits up 4%, buoyed by Victoza and Levemir

Novo Nordisk headquartersBut expects net loss for 2014 from currency impact

Orphan drug market to reach $176bn by 2020

pharmacistNew report suggests market will almost double in five years

Bayer CEO Dekkers points to 'outstanding' pharma growth

Bayer symbolOn target to meet company’s annual expectations of €7.5bn

Boehringer and Lilly to restructure diabetes alliance

Lilly Boehringer diabetes collaborationSay revisions to the alliance will not affect the world's largest markets

Pfizer gets FDA nod for meningitis vaccine Trumenba

Pfizer headquartersAhead of Novartis’ rival drug Bexsero

AZ to work with UK university on drug delivery technologies

The University of ManchesterCompany's staff will also teach parts of courses at The University of Manchester

Sanofi board votes out CEO Viehbacher

Sanofi Chris ViehbacherUnanimous decision ends weeks of speculation

117,000 hepatitis C patients receive Sovaldi so far

gilead-sciences-sovaldiBreakthrough drug has made $8.5bn for Gilead this year

Genes on demandAltering genes on demand

New award-winning research techniques could revolutionise drug discovery

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Business in the USA
The pharma business environment in the US
Tighter regulations, more pricing controls and increased international competition will drive market improvements...
babylon virtual health service
VIDEO: Switching to a virtual health service
Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone...
Online Physician Communities
Is the pharma industry bad?
Surveys of doctors and the public suggest not...